favoxil 50
padagis israel pharmaceuticals ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 50 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).
etodolac teva 400 mg
teva pharmaceutical industries ltd, israel - etodolac - tablets - etodolac 400 mg - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.
nitrolingual spray
megapharm ltd - glyceryl trinitrate - solution - glyceryl trinitrate 0.4 mg/dose - glyceryl trinitrate - glyceryl trinitrate - relief of angina pectoris attacks, angina pectoris prophylaxis.
quinidine sulfate
rekah pharmaceutical industry ltd, israel - quinidine sulfate - tablets - quinidine sulfate 200 mg - antiarrhythmics, class ia - treatment of certain cardiac arrhythmias: atrial fibrillation / flutter and ventricular arrhythmias
pertussol syrup
rekah pharmaceutical industry ltd, israel - benzoic acid as sodium; codeine phosphate; ephedrine hydrochloride; guaiacolsulfonate as potassium - syrup - guaiacolsulfonate as potassium 125 mg / 5 ml; ephedrine hydrochloride 6 mg / 5 ml; benzoic acid as sodium 20 mg / 5 ml; codeine phosphate 2 mg / 5 ml - opium alkaloids and derivatives - for relief of cough.
tocare syrup
rekah pharmaceutical industry ltd, israel - benzoic acid as sodium; codeine phosphate; ephedrine hydrochloride; guaiacolsulfonate as potassium - syrup - benzoic acid as sodium 20 mg / 5 ml; ephedrine hydrochloride 6 mg / 5 ml; guaiacolsulfonate as potassium 125 mg / 5 ml; codeine phosphate 2 mg / 5 ml - opium alkaloids and derivatives - for relief of cough.
simvacor 20
unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 20 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures.reduce the risk of stroke and transient ischemic attacks (tia).hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertrigly
simvacor 10
unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 10 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures. reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertri
simvacor 40
unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 40 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures. reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertrig
simvacor 80
unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 80 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures. reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertri